A wound dressing that stays silent until bacteria attack — then releases antibiotics on its own

Brown University / Science Advances

More than one million people die each year from infections that resist common antibiotics. By 2050, that number could approach ten million annually if overuse continues at current rates. Every unnecessary dose of antibiotics — applied to a wound that turns out not to be infected, sitting on skin that harbors only harmless bacteria — contributes to the pressure that breeds resistant organisms.

A team at Brown University asked a straightforward question: what if the dressing itself could decide when antibiotics are needed?

A lock that only bacteria can pick

The material they developed is a hydrogel — a water-rich, gel-like substance made of long polymer molecules held together by smaller molecules called crosslinkers. Think of the crosslinkers as the rivets holding the structure together. Remove the rivets, and the whole thing falls apart.

The team chose crosslinkers that degrade specifically in the presence of beta-lactamases, enzymes produced by a wide variety of harmful bacteria. When beta-lactamase-producing bacteria colonize a wound, they inadvertently pick the lock on the hydrogel. The crosslinks break. The structure collapses. And the antibiotic cargo trapped inside spills out directly onto the infection.

When no harmful bacteria are present — when only the normal, healthy skin microbiome is in contact with the dressing — the hydrogel stays intact. The antibiotics remain sealed inside. No leaking. No unnecessary exposure.

"It's truly trapped in there until there is a significant amount of beta-lactamase production that can cause hydrogel degradation," said Anita Shukla, a professor in Brown's School of Engineering who led the project.

Selectivity that protects the microbiome

The researchers ran a series of petri dish experiments to confirm the material's selectivity. When exposed to harmless bacteria that don't produce beta-lactamases, the hydrogel remained stable. No degradation, no drug release. Over long-term exposure, these harmless bacteria showed no development of antibiotic resistance — a critical point, since resistance often develops when bacteria encounter low, sustained antibiotic concentrations.

When beta-lactamase-producing bacteria were introduced, the hydrogel degraded and released its payload. The selectivity was consistent across different bacterial strains that produce the enzyme.

This specificity matters beyond the immediate wound. Broad-spectrum antibiotic exposure disrupts the skin's microbial ecosystem, which plays a role in immune function and wound healing. A dressing that leaves healthy bacteria undisturbed while targeting pathogens preserves that ecosystem.

Outperforming the clinical standard in mice

In mouse experiments, the team tested the hydrogel on infected abrasion wounds. A single application of the material fully eradicated bacterial infection. The researchers compared their hydrogel against an antimicrobial wound dressing currently used in clinical settings.

The new material outperformed the standard dressing in two measures: bacterial eradication and wound healing speed. The mice treated with the enzyme-responsive hydrogel cleared their infections faster and showed better tissue repair.

These are mouse results, and the distance from a mouse wound to a human chronic wound is considerable. Mouse skin heals differently from human skin. The bacterial loads, immune responses, and wound environments are not directly comparable. The study did not test the material on the kinds of complex, non-healing wounds — diabetic ulcers, pressure sores, surgical site infections — where antimicrobial resistance poses the greatest clinical threat.

The resistance math

The study sits at the intersection of two problems. The first is wound care: infected wounds heal slowly, and infection control requires antibiotics. The second is antimicrobial resistance: every antibiotic application creates selection pressure for resistant bacteria. Standard wound dressings impregnated with antimicrobials release their cargo continuously, whether bacteria are present or not. That constant, low-level exposure is exactly the scenario most likely to breed resistance.

By limiting antibiotic release to moments when harmful bacteria are actually present, the enzyme-responsive hydrogel reduces total antibiotic exposure without sacrificing treatment. The drug is there when needed. It is absent when it isn't. The bacteria that might develop resistance never encounter the sub-lethal concentrations that drive resistance evolution.

That's the theory. Whether it holds in the messy reality of clinical wound care — with polymicrobial infections, variable bacterial loads, and patients whose immune systems are compromised — remains to be tested.

From lab to bandage

The research team has patented the material and is working toward further development for potential commercialization. The practical challenges are not trivial. Manufacturing a hydrogel with precise crosslinker chemistry at scale, ensuring shelf stability, sterilizing the product without degrading its components, and navigating regulatory approval for a combination device-drug product all stand between the current proof of concept and a product that could sit on a hospital supply shelf.

The work was supported by the Dr. Ralph and Marian Falk Medical Research Trust. The study was published in Science Advances.

Still, the underlying design principle is elegant in its simplicity. Don't decide in advance whether a wound needs antibiotics. Let the bacteria make that decision for you — and build the chemistry so they can only make it by destroying themselves.